Machine learning-guided rational engineering of ACE2-derived peptides for broad-spectrum neutralization of SARS-CoV-2 variants
Saudi Pharmaceutical Journal · 2026-04 · 34 (2)
DOI: 10.1007/s44446-026-00073-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, online erschienen am 31.03.2026. Verfasst von Mubarak A Alamri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, 11942, Al-Kharj, Saudi Arabia. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deanship of Scientific Research, Imam Mohammed Ibn Saud Islamic University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, 11942, Al-Kharj, Saudi Arabia.
- Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), 11623, Riyadh, Saudi Arabia. asalawam@imamu.edu.sa.
Förderung
- Deanship of Scientific Research, Imam Mohammed Ibn Saud Islamic University
Zitieren
APA
Alamri, M. A., & Alawam, A. S. (2026). Machine learning-guided rational engineering of ACE2-derived peptides for broad-spectrum neutralization of SARS-CoV-2 variants. Saudi Pharmaceutical Journal, 34(2). https://doi.org/10.1007/s44446-026-00073-3
Vancouver
Alamri MA, Alawam AS. Machine learning-guided rational engineering of ACE2-derived peptides for broad-spectrum neutralization of SARS-CoV-2 variants. Saudi Pharmaceutical Journal. 2026;34(2). doi:10.1007/s44446-026-00073-3
BibTeX
@article{Alamri2026,
author = {Alamri, Mubarak A and Alawam, Abdullah S},
title = {Machine learning-guided rational engineering of ACE2-derived peptides for broad-spectrum neutralization of SARS-CoV-2 variants},
journal = {Saudi Pharmaceutical Journal},
year = {2026},
volume = {34},
number = {2},
doi = {10.1007/s44446-026-00073-3}
}
EUVIMED